Financhill
Back

Skye Bioscience Quote, Financials, Valuation and Earnings

Skye Bioscience Price Quote

$4.76
-0.75 (-13.61%)
(Updated: November 15, 2024 at 2:40 PM ET)

Skye Bioscience Key Stats

Buy
53
Skye Bioscience (SKYE) is a Buy

Day range:
$5.33 - $5.67
52-week range:
$1.44 - $19.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
559.34
P/B ratio:
2.21%

Volume:
104.6K
Avg. volume:
228.8K
1-year change:
249.84%
Market cap:
$167.2M
Revenue:
$0
EPS:
$-0.84

How Much Does Skye Bioscience Make?

Data Unavailable

Is Skye Bioscience Growing As A Company?

Data Unavailable

Skye Bioscience Stock Price Performance

  • Did Skye Bioscience Stock Go Up Last Month?
    Skye Bioscience share price went up by 34.72% last month
  • Did SKYE's Share Price Rise Over The Last Year?
    SKYE share price rose by 249.84% over the past 1 year

What Is Skye Bioscience 52-Week High & Low?

Skye Bioscience Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Skye Bioscience?

  • How Much Debt Does Skye Bioscience Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Skye Bioscience Have?
    Cash and short term investments quarterly total is $67.4M
  • What Is Skye Bioscience’s Book Value Per Share?
    Book value per share is 2.50

Is Skye Bioscience Cash Flow Positive?

  • What Is SKYE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$20.9M
  • What Is Skye Bioscience’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $83.5M
  • What Is Skye Bioscience’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$343K

Skye Bioscience Return On Invested Capital

Data Unavailable

Skye Bioscience Earnings Date & Stock Price

Skye Bioscience Competitors

  • Who Are Skye Bioscience's Competitors?
    Below is a list of companies who compete with Skye Bioscience or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Oramed Pharmaceuticals Inc (ORMP)
    • Palatin Technologies Inc (PTN)
    • Viking Therapeutics Inc (VKTX)

Skye Bioscience Dividend Yield

Skye Bioscience Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 59.08%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 18.00
Upside from Last Price: 226.68%

Major Shareholders

  • How many SKYE shares are owned by institutional investors?
    532.6M SKYE shares are owned by institutional investors
  • How many SKYE shares are owned by insiders?
    8.5M SKYE shares are owned by insiders